Voreppe, France

Fabien Durand

This inventor holds 26 USPTO granted patents and 21 published patent applications, plus 8 CIPO patents and 31 EPO patents. Top assignees: L'air Liquide,societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude, Centre National De La Recherche Scientifique, Bluebus. Active years: 2014-2026.

USPTO Granted Patents = 26 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Bordeaux, FR (2014 - 2016)
  • Decines, FR (2020)
  • Voreppe, FR (2019 - 2023)
  • Voreppes, FR (2022 - 2023)
  • Sassenage, FR (2023 - 2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Journey of Fabien Durand

Introduction:

Fabien Durand, a visionary inventor hailing from Voreppe, France, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Fabien Durand's latest patents include cutting-edge advancements in renewable energy technology, smart home devices, and sustainable transportation solutions.

Career Highlights:

With a career spanning over two decades, Fabien Durand has established himself as a leading figure in the tech industry. His work has been recognized globally for its ingenuity and impact.

Collaborations:

Throughout his career, Fabien Durand has collaborated with top research institutions, universities, and tech companies to bring his inventions to life. His collaborative spirit has led to the development of revolutionary products that have shaped the industry.

Conclusion:

In conclusion, Fabien Durand's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his place as a trailblazer in the world of technology. His inventions continue to inspire and drive progress in the ever-evolving tech landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…